Skip to main content
Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
0.5007
+0.0184 (3.82%)
Nov 11, 2026, 11:58 AM EST - Market open

Filana Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Profit
-3.85-26.59-69.64-89.42-68.03-24.81
Operating Income
-13.09-60.09-151.35-106.06-80.02-32.87
Net Income
-42.2-90.97-24.34-97.22-76.25-32.39
Earnings Per Share
-0.87-1.88-1.46-2.32-1.90-0.82
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
46.9995.5128.57121.14201.02233.44
Total Debt
----0.140.24
Net Cash (Debt)
46.9995.5128.57121.14200.88233.2
Net Cash Growth
-55.70%-25.72%6.14%-39.70%-13.86%150.18%
Net Cash Per Share
0.971.982.762.895.005.92

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-28.58-32.25-116.93-82.03-77.51-30.2
Capital Expenditures
-0.55-0.58-0.1-0.41-2.71-22.21
Free Cash Flow
-29.13-32.83-117.03-82.44-80.23-52.41
Free Cash Flow Growth
------

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-69.7069.7068.2120.0127.14